Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic insights into thymic carcinomas and thymic neuroendocrine neoplasms denote prognosis signatures and pathways.

Chinese medical journal - 20 Nov 2023

Wang Shuyuan, Gu Zhitao, Zhu Lei, Han Yuchen, Yu Hong, Fang Wentao, Han Baohui

Abstract excerpt

BACKGROUND: Thymic carcinomas (TCs) and thymic neuroendocrine neoplasms (TNENs) are two aggressive subtypes of thymic malignancy. Traditional therapy for advanced TCs and TNENs has limited outcome. New genomic profiling of TCs and TNENs might provide insights that contribute to the development of new treatment approaches. METHODS: We used gene panel sequencing technologies to investigate the genetic aberrations...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to China
Share to Neoplasms, Glandular and Epithelial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neuroendocrine Tumors

Share to Prognosis

Share to Protein-Tyrosine Kinases

Share to Proto-Oncogene Proteins

Share to Thymoma

Share to Thymus Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 37749819
DOI: 10.1097/CM9.0000000000002852
PMCID: PMC10684125

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic insights into thymic carcinomas and thymic neuroendocrine neoplasms denote prognosis signatures and pathways.PMID 37749819Read ↗

Mutation Profile of Thymic Carcinoma and Thymic Neuroendocrine Tumor by Targeted Next-generation Sequencing.Semantic proximity Read ↗

The Molecular Landscape of Thymic Epithelial Tumors: A Comprehensive ReviewSemantic proximity Read ↗

Genetic profiling of thymic carcinoma using targeted next-generation sequencing.Semantic proximity Read ↗

Genomic characterization of thymic epithelial tumors in a real-world datasetSemantic proximity Read ↗

Medical treatment involving investigational drugs and genetic profile of thymic carcinoma.Semantic proximity Read ↗

Integrated Molecular and Clinical Analysis of Thymic Epithelial Tumors.Semantic proximity Read ↗

Characterization of genetic aberrations in a single case of metastatic thymic adenocarcinoma.Semantic proximity Read ↗

Characteristics of Genomic Mutations and Signaling Pathway Alterations in Thymic Epithelial TumorsSemantic proximity Read ↗

Comprehensive Genomic Profiling of 274 Thymic Epithelial Tumors Unveils Oncogenic Pathways and Predictive Biomarkers.Semantic proximity Read ↗

Unraveling molecular networks in thymic epithelial tumors: deciphering the unique signaturesSemantic proximity Read ↗

Mutations of epigenetic regulatory genes are common in thymic carcinomas.Semantic proximity Read ↗

Identification of novel mutations of TP53, ALK and RET gene in metastatic thymic squamous cell carcinoma and its therapeutic implication.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.